Cancer Survivorship SpecialistsPage 45

Curtis Lachowiez, M.D.

Assistant Professor of Medicine, OHSU Knight Cancer Institute

Oncology

Bradley Hunter, MD, MPH

Director of Immune Effector Cell Therapy; Interim Medical Director of Oncology Research; Assistant Professor

Oncology

Julie Fisher, MD

Assistant Professor, Cancer Medicine (Charlotte), Wake Forest University School of Medicine

Oncology

Andre Goy, MD

Chairman and Executive Director, John Theurer Cancer Center; Chief Science Officer and Director of Research and Innovation, RCCA

Oncology

Vera Maranci, M.D.

Assistant Professor, Radiation Oncology, Oakland University William Beaumont School of Medicine

Oncology

Namita Chittoria, MD

Medical Oncologist; Huntsman Cancer Center faculty

Oncology

Andrew Davis, MD

Associate Professor of Medicine, Division of Oncology

Oncology

Harshabad Singh, MD

Instructor in Medicine

Oncology

Jose Leone, M.D.

Associate Professor of Medicine at Harvard Medical School. His research focuses on improving individualized treatment decision-making by quantifying heterogeneity in tre; Director, Program for Breast Cancer in Men

Oncology

Cosmin Tegla, MD

Assistant Professor, Department of Medicine at NYU Grossman School of Medicine

Oncology

Brian Henick, MD

Assistant Professor of Medicine at CUMC; Associate Director, Experimental Therapeutics; Director of Translational Research, Upper Aerodigestive Cancers in Medical Oncology; Director, HICCC Phase I Unit

Oncology

John Sprandio, MD

Oncology

Ricardo Costa, MD

Assistant Member, Department of Breast Oncology

Oncology

Patrick McLaughlin, MD

Oncology

Aleda Toma, M.D.

Medical Oncologist

Oncology

Wallace Akerley, MD

Professor of Medicine

Oncology

Timothy Voorhees, M.D.

Assistant Professor of Internal Medicine – Clinical, Division of Hematology, The Ohio State University Wexner Medical Center

Oncology

Mary Daly, M.D.

Professor, Department of Clinical Genetics; Director, Risk Assessment Program; Former Chair, Department of Clinical Genetics

Oncology

Martin Gutierrez, MD

Director of the Drug Discovery/Phase I Unit

Oncology

Zaw Bo, M.D.

Oncology